Announcement Regarding the Completion of Absorption-type Merger of Wholly-Owned Subsidiary (GENOVA DESiGN Inc.)

GENOVA Inc. has completed the absorption-type merger of its wholly-owned subsidiary, GENOVA DESiGN Inc. (GD Inc.), effective April 1, 2026. This merger aims to strengthen collaboration between GENOVA's medical platform business and its production department, accelerate decision-making, improve service quality, and enhance corporate value through reduced administrative costs. The merger, being with a 100% owned subsidiary, will not impact consolidated business performance.
M&ANQ 100/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 2, 2026 at 00:30
  • 🔍 Collected: April 1, 2026 at 16:47
  • 🤖 AI Analyzed: April 17, 2026 at 02:27 (369h 40m after Collected)
GENOVA Inc. (Head Office: Shibuya-ku, Tokyo; Representative Director and President: Tomoki Hirase; hereinafter: "the Company") announces that, as disclosed in the timely disclosure dated February 13, 2026, titled "Announcement Regarding the Absorption-type Merger (Simplified Merger/Short-Form Merger) of Wholly-Owned Subsidiary (GENOVA DESiGN Inc.)," the absorption-type merger of its wholly-owned subsidiary, GENOVA DESiGN Inc. (hereinafter: "GD Inc."), was completed today, April 1, 2026. ■Purpose of Merger GD Inc., the merged company, has been responsible for creative functions such as web design and content production for the Company's services as a 100% consolidated subsidiary. Through this absorption-type merger, we aim to strengthen the collaboration between our main business, the medical platform business, and our production department, thereby accelerating decision-making and improving service quality. Concurrently, we will promote operational efficiency by reducing administrative costs and strive to further enhance corporate value. ■Summary of Merger * Merger Method: This is an absorption-type merger where the Company is the surviving company and GD Inc. is the absorbed company. * Effective Date: April 1, 2026 * Allotment of Shares, etc.: There will be no issuance of new shares or payment of merger consideration due to this merger. ■Overview of Merging Companies (Please refer to the original article for the image.) ■Status After Merger There will be no changes to the Company's trade name, location, representative, business activities, capital, or fiscal year due to this merger. ■Future Outlook Since this merger is between the Company and its wholly-owned subsidiary, there will be no impact on consolidated business performance. ###■About GENOVA Inc. GENOVA Inc. is a company that provides innovative healthcare tech services with the mission of "connecting people and medicine to create a healthy society." We are developing diverse businesses to solve social issues such as responding to the shortage of medical personnel due to Japan's declining birthrate and aging population, and the need to promote healthy life expectancy and appropriate medical access due to increasing national healthcare costs. Through the services we provide, we aim to resolve medical and health anxieties and dissatisfactions for patients and users, and to provide higher quality medical experiences. 【Company Profile】 GENOVA Inc. Location: Shibuya Hikarie 34F, 2-21-1 Shibuya, Shibuya-ku, Tokyo Shibuya Axsh 23F, 2-17-1 Shibuya, Shibuya-ku, Tokyo Representative: Tomoki Hirase, Representative Director and President URL: https://genova.co.jp 【Contact Information for this matter】 Contact Form: https://genova.co.jp/contactform